Hemp Cannabinoid List Still Missing? FDA Deadline and Timeline

Yes, FDA is behind schedule. Congress set a February 10, 2026 deadline for FDA to put out three cannabinoid lists plus information on what “container” means, and as of November 9, 2026 Marijuana Moment says none of it has appeared. Marijuana Moment says this is at least the third time the Congressional Research Service has flagged the delay. The dates you are most likely to see in headlines are November 12, 2026 and December 11, 2026, so this page walks through what was ordered, what has been reported, and who to ask about your own situation.

Affiliate disclosure: Heads up, affiliate links appear on this page. If you buy through one of them, this site may earn a commission. This costs you nothing extra.

Quick facts as of 2026-11-09

What did Congress order FDA to publish?

Marijuana Moment reports that the 2025 law gave FDA 90 days to publish three lists and information on the word “container.” The lists cover:

• all cannabinoids FDA knows the cannabis plant can make naturally
• all THC-class cannabinoids known to occur naturally in the plant
• any other known cannabinoid that has, or is sold as having, comparable effects

Under the statute, a container is the inner layer that is in contact with the finished hemp product and closed for sale at retail. Jars, bottles, bags, boxes, packets, cans, cartons and cartridges can all qualify. The 0.4 milligram figure is stated per container, which is why this definition is part of the picture.

What did the Congressional Research Service report?

The Congressional Research Service Legal Sidebar LSB11496, published in late October 2026, reports that FDA had not published any of these items as of that publication.

What did HHS and hemp businesses say about the delay?

An HHS spokesperson told Marijuana Moment earlier in 2026 that the agency intended to provide the lists in time and publish them in the Federal Register. FDA did not reply to Marijuana Moment’s new requests.

Jim Higdon of Cornbread Hemp told Marijuana Moment in August that complying with the law is hard while key definitions remain unsettled. That is why a hemp business says planning is hard right now. Marijuana Moment also reports that several bipartisan bills to regulate hemp THC products exist, and none has gained traction with congressional leadership.

What are the key dates?

• February 10, 2026: deadline for FDA’s lists and container information. It passed without publication.
• Late October 2026: the CRS Legal Sidebar reports that none of the items had been published.
• November 5, 2026: Illinois hemp groups file for a temporary restraining order and preliminary injunction.
• November 12, 2026: the Illinois Hemp Act is set to take effect, and the synthetic cannabinoid carve-out takes effect.
• December 11, 2026: Marijuana Moment reports the ban’s effective date for most products is pushed to this date under a funding bill signed in September 2026, and products with 0.4 milligrams of total THC per container remain legal.

As of November 9, 2026, no ruling or hearing date had been reported in the Illinois case, and no date had been announced for the DEA judge’s recommendation or the DEA administrator’s final decision in the marijuana hearing.

What are hemp-derived cannabinoid products?

Hemp-derived cannabinoid products come from the hemp plant, and federal law treats hemp differently from marijuana. Marijuana Moment reports that the 2018 Farm Bill legalized hemp derivatives with under 0.3 percent delta-9 THC on a dry-weight basis. The 2025 law then redefined hemp so that only products with 0.4 milligrams of total THC per container remain legal.

The law’s carve-out for synthetics is written around compounds that a Cannabis sativa L. plant cannot naturally produce. The MedlinePlus cannabis health topic page from the National Library of Medicine explains that the main active chemicals in cannabis are cannabinoids. It says THC is the compound behind the “high,” and CBD is not. For more on how these compounds act in the body, read the endocannabinoid system and botanical interactions. To compare two of these compounds, see CBD vs CBN.

On safety, a 2026 study of hemp adverse reactions, published in Drugs – real world outcomes, reviewed FDA adverse event reports from January 1, 2004 to June 30, 2025. It found 1,712 reports involving hemp products. Seizures, anxiety and depression were the reactions most strongly associated with hemp. The authors concluded that hemp-derived products are associated with adverse drug reactions, including serious neurological and psychiatric events.

Common mix-ups

Who does this affect, and how?

Hemp shoppers and businesses

Jim Higdon’s point is the one to keep in mind: when key definitions are still open, compliance is hard. Store owners and buyers can ask their state agency or an attorney how the dates and limits apply to what they sell or buy.

Illinois

The CBS Chicago report on the Illinois lawsuit says the law is aimed at unregulated THC products, including many well-known beverages. Craig Kats of the Illinois Healthy Alternatives Association told CBS Chicago that most products in member stores are low potency. He described customers as mostly middle-aged and older adults, including Army veterans and seniors, who use them for stress, anxiety or pain relief rather than to get high. State leaders say the ban shields consumers, children in particular, from unregulated products with misleading labels and packaging.

NewsChannel 20 reports that the plaintiffs argue the Illinois Hemp Act violates the Commerce Clause of the U.S. Constitution by shutting out-of-state companies from Illinois markets. They describe Illinois hemp as a half-billion-dollar industry.

New Jersey workers

The Forbes report on New Jersey bill by Alonzo Martinez says New Jersey’s 2021 legalization law, known as CREAMMA, generally bars employers from refusing to hire, firing or penalizing someone for lawful off-duty marijuana use. As a rule, a positive drug test by itself does not justify an adverse employment decision.

Senate Bill 4685, introduced October 1, 2026, and identical Assembly Bill 5649, introduced October 19, would create an exception for specified safety-sensitive workers. That group includes certain full-time law enforcement officers, paid firefighters, EMTs, paramedics, paid 9-1-1 dispatchers and commercial drivers. For those workers, the bills would let employers act on a positive test for cannabinoid metabolites alone, without evidence of impairment at work. Both bills remain pending, and existing protections continue to apply until then.

Forbes also notes that THC and its metabolites can stay detectable after impairing effects end, so a positive test may show earlier use rather than impairment. New Jersey’s Cannabis Regulatory Commission 2022 workplace guidance recommends documenting observable signs of impairment.

Commercial drivers under federal DOT drug testing rules remain barred from marijuana regardless of state law, and DOT has reaffirmed this. Medical cannabis patients have separate protection under the Jake Honig Compassionate Use Medical Cannabis Act. For a specific job situation, ask an employment attorney, your union or the state labor department.

What is the DEA marijuana hearing?

Marijuana Moment reports that Attorney General Todd Blanche issued an order in April 2026 that immediately moved state-licensed medical cannabis and FDA-approved marijuana products from Schedule I to Schedule III. A separate DEA hearing in June and July 2026 considered moving marijuana more broadly to Schedule III. On November 5, 2026, DEA and the participating opponents filed what are expected to be the final briefs before DEA Chief Administrative Law Judge Derek Julius issues a recommendation to the DEA administrator. This track is separate from the hemp definitions above.

Who should you ask about your next step?

• Business owners: an attorney who handles hemp or cannabis law, and your state agency.
• Illinois sellers: your state agency and your attorney, since the lawsuit is pending.
• Workers in New Jersey: an employment attorney, your union, or the state labor department.
• Health questions about these products: a clinician.

Before you decide

• Whether FDA publishes the lists and container information in the Federal Register, as HHS said it intends.
• Whether the Illinois court acts before November 12, 2026.
• Whether the December 11, 2026 date holds for most products, as Marijuana Moment reports.

By KratomCBDDirect.com Editorial Team